{"database": "lobbying", "table": "lobbying_activities", "rows": [[2189922, "53f8389c-ce29-45ac-b76e-64371bc00b18", "Q3", "RUBICON ADVISORS, LLC", 315091, "DR. REDDY'S LABORATORIES, LTD", 2018, "third_quarter", "PHA", "Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues", "Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 45000, null, 0, 0, "2018-10-18T09:52:08.403000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2189922"], "units": {}, "query_ms": 11.201804038137197, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}